First Trust Nasdaq Pharmaceuticals ETF
Health/Biotechnology
FTXH
120 East Liberty Drive, Suite 400,
Wheaton , IL, 60187
Wheaton , IL, 60187
Price
-
$ 27.81
0 %
+0.18
Feb 20, 2025
- Last Close
- Net Assets
-
$18.6M
Feb 26, 2024
- 52-Week High/Low
- $29.58 - $25.67
- Expense Ratio
- -
Link
Directors
Jun 8, 2023- Richard E. Erickson
- Thomas R. Kadlec
- Denise M. Keefe
- Robert F. Keith
- Niel B. Nielson
- James A. Bowen
Chief Compliance Officer
- Kristi A. Maher
Company Name |
Holding |
| More | 1.19 % |
Documents
Returns +
Q
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Q1 | - | 5.4% | -4.9% | -1% | -0.7% | -16.7% |
| Q2 | - | -5.5% | 0.3% | -0.7% | 2.2% | 17.3% |
| Q3 | - | - | -2.4% | -9.1% | -1.5% | 5% |
| Q4 | - | - | 4.6% | 14.1% | 5.4% | 6.7% |
Returns +
M
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | 2.3% | 2.2% | 0.8% | -7.5% | 1.1% | - | - | - | - | - | - | - |
Returns +
A
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0% | -1.5% | -3% | 2.1% | 5.4% | 9.5% | 21.4% | -9.5% | 19.4% | 0% | -7.8% |